AHA yesterday sent a letter to the Department of Justice’s Antitrust Division expressing its serious concern with the adequacy of any remedy to resolve the anticompetitive impact of UnitedHealth Group’s acquisition of Change Healthcare. UHG in January announced its intent to combine its Optum health services subsidiary with Change Healthcare, a health care technology firm, to provide software and data analytics, technology-enabled services and research, advisory and revenue cycle management services.

At the time, AHA argued that the deal would distort “decisions about patient care and claims processing and denials to the detriment of consumers and health care providers and further increase UHG’s already massive market power.” In the newest letter AHA reiterated that “it is highly unlikely that any remedy will preserve the substantial level of competition between the parties that will be lost if the transaction is completed.”

Related News Articles

Headline
The U.S. District Court of the Eastern District of Louisiana Sept. 27 ruled in favor of a LCMC Health and Tulane University partnership, concluding that the…
Headline
Congress should urge the Department of Health and Human Services’ Office for Civil Rights to immediately withdraw its new rule regarding so-called “online…
Headline
The Senate Sept. 26 voted 77-19 to begin debate on a continuing resolution that would continue funding for government programs through Nov. 17. The Senate…
Perspective
As we’ve seen from recent media reports, Congress — and especially the House right now — continues to struggle to put together a plan to keep the government…
Headline
AHA Sept. 20 urged leaders of the Senate Health, Education, Labor and Pensions Committee to remove from the Bipartisan Primary Care and Health Workforce…
Headline
Certain policy decisions and challenges in implementing the No Surprises Act have undermined the unbiased and timely process Congress intended and contributed…